SI21616A - Nove kristalne oblike karvedilola - Google Patents

Nove kristalne oblike karvedilola Download PDF

Info

Publication number
SI21616A
SI21616A SI200300218A SI200300218A SI21616A SI 21616 A SI21616 A SI 21616A SI 200300218 A SI200300218 A SI 200300218A SI 200300218 A SI200300218 A SI 200300218A SI 21616 A SI21616 A SI 21616A
Authority
SI
Slovenia
Prior art keywords
carvedilol
ethyl acetate
carvedilol form
crystalline
crystalline carvedilol
Prior art date
Application number
SI200300218A
Other languages
English (en)
Slovenian (sl)
Inventor
Rok Zupet
Marija Grčman
Matej Smrkolj
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority to SI200300218A priority Critical patent/SI21616A/sl
Priority to EP04775682A priority patent/EP1660451A2/fr
Priority to PCT/SI2004/000029 priority patent/WO2005021504A2/fr
Publication of SI21616A publication Critical patent/SI21616A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SI200300218A 2003-09-02 2003-09-02 Nove kristalne oblike karvedilola SI21616A (sl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SI200300218A SI21616A (sl) 2003-09-02 2003-09-02 Nove kristalne oblike karvedilola
EP04775682A EP1660451A2 (fr) 2003-09-02 2004-09-01 Nouvelles formes cristallines de carvedilol
PCT/SI2004/000029 WO2005021504A2 (fr) 2003-09-02 2004-09-01 Nouvelles formes cristallines de carvedilol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300218A SI21616A (sl) 2003-09-02 2003-09-02 Nove kristalne oblike karvedilola

Publications (1)

Publication Number Publication Date
SI21616A true SI21616A (sl) 2005-04-30

Family

ID=34271325

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200300218A SI21616A (sl) 2003-09-02 2003-09-02 Nove kristalne oblike karvedilola

Country Status (3)

Country Link
EP (1) EP1660451A2 (fr)
SI (1) SI21616A (fr)
WO (1) WO2005021504A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02012795A (es) 2000-06-28 2004-07-30 Teva Pharma Carvedilol.
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
WO2006135757A1 (fr) * 2005-06-09 2006-12-21 Teva Pharmaceutical Industries Ltd. Formes cristallines du carvedilol et leurs procedes de preparation
WO2007043938A1 (fr) * 2005-10-07 2007-04-19 Astrazeneca Ab Nouvelle forme cristalline de 3,5-dibromo-n-[(2s)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-n-methylbenzamide, modification b
EP1991527A2 (fr) 2006-06-28 2008-11-19 Teva Pharmaceutical Industries Ltd Formes polymorphes de carvédilol phosphate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893440A1 (fr) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Une modification thermodynamique stabilisée de 1-(4-carbazolyloxy)-3[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, un procédé pour sa préparation et une composition pharmaceutique qui la contient
MXPA02012795A (es) * 2000-06-28 2004-07-30 Teva Pharma Carvedilol.
DE60212130D1 (en) * 2001-07-13 2006-07-20 Smithkline Beecham Corp Carvedilolpolymorph
DE60221683T2 (de) * 2001-09-28 2008-04-30 F. Hoffmann-La Roche Ag Pseudopolymorphe formen von carvedilol
MXPA04006909A (es) * 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
SK285547B6 (sk) * 2002-11-08 2007-03-01 Zentiva, A. S. Spôsob prípravy Carvedilolu
WO2004041252A1 (fr) * 2002-11-08 2004-05-21 Egalet A/S Compositions de carvedilol a liberation commandee
WO2004113296A1 (fr) * 2003-06-20 2004-12-29 Sun Pharmaceutical Industries Limited Procede de preparation de 1-[9h-carbazol-4-yloxy]- 3-[{2-(2-(-(methoxy)phenoxy)-ethyl}-amino]-propane-2-ol

Also Published As

Publication number Publication date
WO2005021504A3 (fr) 2005-06-02
EP1660451A2 (fr) 2006-05-31
WO2005021504A2 (fr) 2005-03-10

Similar Documents

Publication Publication Date Title
WO2017008773A1 (fr) Formes cristallines d'acide obéticholique
EP1939176A1 (fr) Sels de Tegaserod
CZ289730B6 (cs) Krystalický hydrochlorid (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-budyl]-aminomethyl}-chromanu, způsob jeho výroby, farmaceutický prostředek tuto látku obsahující a její pouľití
EP2468762A1 (fr) Synthèse optimisée d'acides biliaires purs, cristallins et non polymorphes avec une taille de particules définie
EP2601175A1 (fr) Nouveau composé cristallin comprenant de la saxagliptine et de l'acide phosphorique
SI21616A (sl) Nove kristalne oblike karvedilola
CA2485262A1 (fr) Nouvelles formes cristallines de gatifloxacine
CA2579119A1 (fr) Formes cristallines du sel monosodique de d-isoglutamyl-d-tryptophane
WO2012156383A1 (fr) Nouveaux sels cristallins d'asénapine contenant des diacides et triacides organiques
US9981985B2 (en) Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation
EP3398946B1 (fr) Sel de dérivé de morpholine et sa forme cristalline, et procédé de préparation, composition pharmaceutique et utilisation de ce dernier
SK107694A3 (en) 3/2 hydrate and anhydrate 7-£(7-(s)-amino-5-azaspiro £2.4|- -heptane-5-yl|-8-chlorine-6-fluoro-1-£(1r,2s)-2- -fluorocyclopropyl-4-oxo-1,4-dihydroquinoline -3- carboxylic acid, method of selective production of 3/2 hydrate, its crystals and antibacterial agents on its base
WO2020119772A1 (fr) Substance de chlorhydrate de mefuparib polymorphe et procédé de préparation correspondant
MXPA01012328A (es) Polimorfos de un citrato de (2-benzhidril- 1-azabiciclo(2.2.2) oct-3-il- (5-iso- propil-2- metoxibencil) -amina como antagonistas del receptor de nk-1.
WO2012150183A1 (fr) Sel de sodium cristallin d'un inhibiteur d'intégrase du vih
WO2002060441A1 (fr) Nouvelles formes de 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide
EP2159225A1 (fr) Procédé de gémifloxacine et polymorphes
EP1713769B1 (fr) Chlorhydrate de tamsulosine amorphe
EP3372592A1 (fr) Formes solides de sels d'amines de lesinurad
US20090326005A1 (en) Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
CN116041323A (zh) Sigma-1受体激动剂的酸式盐、其晶型及其制备方法和应用
EP1768961A1 (fr) Nouvelle forme du celecoxib
KR100749219B1 (ko) 신규한 로지글리타존 옥살산염, 이의 제조방법, 및 이를포함하는 약제학적 조성물

Legal Events

Date Code Title Description
OO00 Grant of patent

Effective date: 20040312

KO00 Lapse of patent

Effective date: 20080415